Validity and Reliability of the Turkish Version of the Manual Dexterity Questionnaire
Launched by BANDIRMA ONYEDI EYLÜL UNIVERSITY · Feb 10, 2025
Trial Information
Current as of November 08, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is an observational effort to check whether a Turkish version of the Dexterity Questionnaire (DextQ-24) is accurate and reliable for people with Parkinson’s disease. In addition to the DextQ-24, researchers will gather other quick tests that measure hand function and overall PD impact to understand how well the Turkish questionnaire works in daily life settings.
If you are eligible, you would be a Parkinson’s patient aged 40–80, in Hoehn and Yahr stages I–IV, and have a Mini-Mental State Exam score above 24. About 120 people are being invited to participate at Bandırma Onyedi Eylül University in Turkey. The visit lasts about 30 minutes and involves consent, some brief tests (including the Nine-Hole Peg Test and a few PD scales). A subset of about 30 participants will retake the Turkish DextQ-24 after two weeks to check the questionnaire’s reliability. This is not a treatment study; there are no drugs or devices being tested, and the aim is to support better clinical assessment of hand function in Turkish-speaking patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Willingness to participate in the study voluntarily
- • A confirmed diagnosis of Parkinson's disease
- • Age range between 40 and 80 years
- • Disease stage classified as Hoehn \& Yahr Stage I-IV
- • Mini-Mental State Examination (MMSE) score \>24
- Exclusion Criteria:
- • Presence of any neurological disease other than Parkinson's disease (e.g., multiple sclerosis, muscular disorders, stroke)
- • History of any surgical procedure involving the upper extremities
- • Presence of hand deformities unrelated to Parkinson's disease (e.g., rheumatoid arthritis, nerve injury, connective tissue disorders)
About Bandırma Onyedi Eylül University
Bandırma Onyedi Eylül University is a reputable academic institution committed to advancing medical research and innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate high-quality research initiatives aimed at improving healthcare outcomes. With a focus on collaboration and ethical standards, Bandırma Onyedi Eylül University actively engages in studies that explore novel treatments and interventions, contributing to the body of scientific knowledge while prioritizing patient safety and well-being. Through its dedication to rigorous research methodologies and multidisciplinary approaches, the university plays a vital role in the development of evidence-based practices in the medical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bandirma, Balıkesir, Turkey
Bandirma, Turkey
Patients applied
Trial Officials
Gulhan Yilmaz Gokmen, Assos. Prof.
Study Chair
Bandırma Onyedi Eylül University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported